Eurofins DiscoverX
Shilpi Sengar is a Scientist-Lead at Eurofins DiscoverX, with experience in culturing and maintaining various cell lines such as CHO, HEK, U2OS, and KILR. Prior to this role, Shilpi worked as a Research Assistant at Translational Bioscience, managing over 280 cell lines for immunoassays. Shilpi also has experience as a Research Intern at Sanford Burnham Prebys Medical Discovery Institute, where they worked on pancreatic cancer cell lines to study metastatic pathways. Shilpi holds a Master's degree in Life Science and has completed Biotechnology Research Associate courses at Ohlone College.
Eurofins DiscoverX
DiscoveRx:registered: is an innovative company that develops, manufactures, and commercializes reagents, complete cell-based assay kits, profiling and screening services as well as other turn-key solutions for the drug discovery, screening, and life science markets. Our biochemical and cell-based assays enable customers to improve researchproductivity and effectiveness of their screening, lead optimization and SAR campaigns, thus accelerating the discovery and development of new drug